Matthew Gentry, "Compartmentalized pathogenic glycogen causes disease and a therapy to remove it"

Monday, January 14, 2019

4:00 pm

Clark Center Auditorium S001 Map

Sponsored by:
Department of Biology

Matthew S. Gentry, PhD., is Professor in the College of Medicine at the University of Kentucky where he oversees projects on both Lafora disease and biofuels research. The lab focuses on the regulation of specific phosphatases and E3 ubiquitin ligases in both human glycogen and plant starch metabolism utilizing in vitro biochemical and structural techniques; in situ cell culture models; and in vivo mouse, algal and plant models. Dr. Gentry has been continuously funded by NINDS since 2006, he is an NIH K99/R00 Pathway to Independence Award recipient, he received the NIH Young Investigator IDeA Maciag Award, he is an NSF CAREER awardee, and PI of both a NINDS R01 and P01. He is a Journal of Biological Chemistry Editorial Board member, he is on the Executive Committee of the ASBMB Public Action Advocacy Committee (PAAC), and he is a member multiple study sections.

When:
Monday, January 14, 2019
4:00 pm – 5:00 pm
Where:
Clark Center Auditorium S001 Map
Admission:

Free and open to the public.

Tags:

Seminar Science 

Audience:
General Public, Faculty/Staff, Students, Alumni/Friends, Members
Contact:
723-2413, ezavala@stanford.edu